approval
saveZYNYZ (RETIFANLIMAB-DLWR) — FDA approval
community read0 votes
Sponsor: INCYTE CORP. Form: INJECTABLE. Route: INTRAVENOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 5
- phase 3 initiationIncyte Corp — retifanlimab (Phase III Trial Initiation)Apr 29, 2026 · 163d ago
- approvalZYNYZ (RETIFANLIMAB-DLWR) — FDA approvalMar 30, 2026 · 193d ago
- approvalZYNYZ (RETIFANLIMAB-DLWR) — FDA approvalMay 15, 2025 · 512d ago
- approvalZYNYZ (RETIFANLIMAB-DLWR) — FDA approvalApr 22, 2024 · 900d ago
- approvalZYNYZ (RETIFANLIMAB-DLWR) — FDA approvalMar 22, 2023 · 1297d ago
comments(0)
5-min edit window · permanent after that